Abstract
Natural agents are emerging as candidates with strong potential for targeted therapy against cancer as “nutraceuticals.” Deguelin, a rotenoid isolated from Mundulea sericea (Leguminosae) or Derris trifoliata, has been identified as a potent chemopreventive nutraceutical. Compendium of literature exhibiting its significant antitumorigenesis and antiproliferative activity in various types of cancer both in vitro and in vivo has recommended deguelin as a novel nutraceutical targeting tumorigenesis, apoptosis, cell-cycle arrest, and anti-angiogenesis for cancer chemoprevention and chemotherapy. In this chapter, we provide an overall insight on the role of deguelin as a chemosensitizer and its mechanism of action against cancer.
| Original language | English |
|---|---|
| Title of host publication | Role of Nutraceuticals in Cancer Chemosensitization |
| Subtitle of host publication | Volume 2 |
| Publisher | Elsevier |
| Pages | 287-296 |
| Number of pages | 10 |
| Volume | 2 |
| ISBN (Electronic) | 9780128123737 |
| ISBN (Print) | 9780128123744 |
| DOIs | |
| State | Published - 1 Jan 2017 |
| Externally published | Yes |
Keywords
- Cancer
- Chemoprevention
- Deguelin
- Mechanism
- Nutraceuticals
ASJC Scopus subject areas
- General Medicine
- General Biochemistry, Genetics and Molecular Biology